Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Once certain particles were ionized, however, it was necessary to find a way to see them through the noise. It was not until late 1971, according to Hamish, that he and his colleagues developed a chromatographic method that used ion exchange as the separation mode and conductivity monitoring as the means of detection.
It acquired Durrum in 1974.
In September 1975, the first commercial IC instrument made its public debut at the fall meeting of the American Chemical Society, demonstrated in the back of a rented van.
1975: Dow Chemical licenses Ion Chromatography technology to Durrum Instrument.
The IC business unit was spun-off in 1978.
1980: Dionex incorporated as separate entity; A. Blaine Bowman becomes CEO.
In 1984, Dionex took a major step when it offered the first PC-based IC workstation and the first on-line IC system from process analysis.
Dionex would be reincorporated as a Delaware company in 1986.
Dionex's research efforts then produced a revolutionary breakthrough in IC technology with the 1986 introduction of its MicroMembrane suppressors, which now made gradient elution possible meaning the types of ions that could be analyzed grew substantially.
By the end of fiscal 1987, sales would top $50 million.
In fiscal 1994, Dionex introduced its PeakNet Windows-based software, which was incorporated into a new line of PC-based IC workstations.
In January 2001, it increased it direct sales subsidiaries by opening offices in Denmark and China.
By fiscal 2001, revenues would improve to $176.8 million and net income to $31.4 million.
Rate Dionex Corporation's efforts to communicate its history to employees.
Do you work at Dionex Corporation?
Does Dionex Corporation communicate its history to new hires?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Beckman Coulter | 1935 | $3.7B | 12,000 | 2 |
| Danaher | 1969 | $23.9B | 80,000 | 1,654 |
| NuVasive | 1997 | $1.2B | 2,800 | - |
| Varian Medical Systems | 1948 | $3.2B | 10,000 | 2 |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 739 |
| Wyatt Technology | 1982 | $22.7M | 50 | 2 |
| LI-COR | 1971 | $90.0M | 200 | 3 |
| Caliper Life Sciences | 1995 | $109.8M | 200 | - |
| Ardent Technologies | - | $1.6M | 30 | - |
| Seagen | 1997 | $2.0B | 900 | - |
Zippia gives an in-depth look into the details of Dionex Corporation, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Dionex Corporation. The employee data is based on information from people who have self-reported their past or current employments at Dionex Corporation. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Dionex Corporation. The data presented on this page does not represent the view of Dionex Corporation and its employees or that of Zippia.
Dionex Corporation may also be known as or be related to DIONEX CORP, Dionex, Dionex Corp and Dionex Corporation.